a
<We_can_help/>

What are you looking for?

>Jannick Bendtsen
speaker_info

About The Speaker

Jannick Bendtsen

Jannick is co-founder and CEO of PipeBio

Jannick Bendtsen

Jannick is co-founder and CEO of PipeBio, a leading bioinformatics platform catering to pharmaceutical and biotech companies engaged in antibody and therapeutic peptide research.

Jannick holds a MSc in molecular biology and a PhD in bioinformatics and has an impressive scientific profile with more than 12,000 citations. Accumulating more than 17 years of experience in the bioinformatics industry, he has been an integral part of successful companies such as CLC bio, QIAGEN, and Biomatters.

Currently, Jannick leads an exceptionally innovative enterprise that envisions the cure of life-altering diseases like cancer and COVID-19. Through a cutting-edge bioinformatics platform powered by machine learning, PipeBio enables pharmaceutical drug companies to accelerate the development of high-quality antibodies, thereby revolutionizing the industry.

An integrated bioinformatics platform for antibody discovery: Advancing data-driven decision making for therapeutic candidate selection

The swift identification of promising antibody candidates from various generation methods is crucial for driving therapeutic development. This presentation addresses the practical role of in silico analysis in expediting this process with adaptable and user-friendly bioinformatics tools.

We discuss solutions for tackling challenges in processing and handling antibody data using the PipeBio platform. This integrated cloud application provides a seamless, no-code approach for end-to-end bioinformatic workflows and data management in the discovery of therapeutic antibodies and biologics.

Register free for upcoming on-demand talks